Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-response and exposure of BC222 insulin lispro vs Humalog in type 1 diabetes
2014-000949-77Phase 2Completed
- Sponsor
- Adocia
- Start
- Mar 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of BioChaperone Lispro in diabetes mellitus type 1 (T1D), sponsored by Adocia. Primary endpoint: AUCGIR(0-last). Started Mar 2014; status: completed.
02
Drugs
BioChaperone Lispro
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2014-000949-77.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000949-77.